Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.

Autor: Patmore LA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Electronic address: l.patmore@erasmusmc.nl., Katwaroe WK; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van der Spek D; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Choi HSJ; Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, Canada., Patel K; Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, Canada., Brakenhoff S; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van der Meer AJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van Kleef LA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., de Knegt RJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Hansen BE; Department of Epidemiology and Biostatistics, Erasmus MC University Medical Center, Rotterdam, The Netherlands., de Man RA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Feld JJ; Department of Epidemiology and Biostatistics, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Janssen HLA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands; Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, Canada., Sonneveld MJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2023 Nov; Vol. 21 (12), pp. 3089-3096.e1. Date of Electronic Publication: 2023 Mar 31.

Higher hepatitis B surface antigen loss among whites compared to asians after stopping nucleos(t)ide analogue therapy in a large, global, multiethnic cohort of patients with chronic hepatitis B.

Autor: Hirode, G., Hansen, B. E., Chen, C.-H., Su, T.-H., Seto, W.-K., Wong, G., Van Hees, S., Papatheodoridi, M., Lens, S., Brakenhoff, S. M., Choi, H. S. J., Chien, R.-N., Feld, J. J., Sonneveld, M., Forns, X., Papatheodoridis, G. V., Vanwolleghem, T., Chan, H. L. Y., Yuen, M.-F., Kao, J.-H.

Publikováno v: Canadian Liver Journal; Spring2021, Vol. 4 Issue 2, p207-209, 3p

Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis.

Autor: Lazarevic, Ivana¹ (AUTHOR) danijela.karalic@med.bg.ac.rs, Miljanovic, Danijela¹ (AUTHOR) ana.banko@med.bg.ac.rs, Banko, Ana¹ (AUTHOR) maja.cupic@med.bg.ac.rs, Cupic, Maja¹ (AUTHOR), Cirkovic, Andja² (AUTHOR) andja.cirkovic@med.bg.ac.rs

Publikováno v: Viruses (1999-4915). Jul2024, Vol. 16 Issue 7, p1121. 18p.

Treatment of diabetes mellitus in patients with chronic hepatitis B: Are SGLT2 inhibitors hitting the sweet spot?

Autor: Sonneveld MJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Janssen HLA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2023 Nov 01; Vol. 78 (5), pp. 1334-1336. Date of Electronic Publication: 2023 Apr 27.

Liver stiffness improvement in hepatitis c patients after successful treatment

Autor: Brakenhoff, S. M., Verburgh, M. L., Willemse, S. B., Baak, L. C., Brinkman, K., Marc van der Valk

Publikováno v: Scopus-Elsevier
Netherlands journal of medicine, 78(6), 368-375. Van Zuiden Communications BV

Background: Successful treatment of chronic hepatitis C with direct-acting antiviral agents (DAAs) is expected to lead to improvement in liver fibrosis in most of the patients. However, limited data are available on the improvement of advanced liver

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d5e83f8846d5cc476287dd3eba1e2be6
http://www.scopus.com/inward/record.url?eid=2-s2.0-85098254807&partnerID=MN8TOARS